ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01709500
Brief Title: Study of Alirocumab (REGN727/SAR236553) in Patients With heFH (Heterozygous Familial Hypercholesterolemia) Who Are Not Adequately Controlled With Their LMT (Lipid-Modifying Therapy) (ODYSSEY FH II)

First Submitted : October 8, 2012
First Submitted that Met QC Criteria : October 16, 2012
First Posted : October 18, 2012 (Estimate)

Results First Submitted : July 29, 2015
Results First Submitted that Met QC Criteria : September 29, 2015
Results First Posted : October 28, 2015 (Estimate)

Certification/Extension First Submitted : January 24, 2015
Certification/Extension First Submitted that Met QC Criteria : January 24, 2015
Certification/Extension First Posted : February 2, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : September 29, 2015
Last Update Posted : October 28, 2015 (Estimate)